| Name | Title | Contact Details |
|---|
Founded in 1999, Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class - while empowering our community to take control of diabetes.
LSL Industries is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2004 by Rob Landerholm, MD FACS and Peter Billing, MD FACS, Eviva set out to provide excellence in patient care with a focus on leading edge bariatric (weight loss) surgery. Prominently known as industry leaders in bariatrics, Eviva has also maintained steady growth in a variety of services. The objective of our founding surgeons has come to fruition and we are pleased to have acquired a growing team of physicians and specialized care providers who share the same goals. We are leaders in performing advanced laparoscopic surgical procedures as well as a variety of specialty and preventative care services. Surgical care options include bariatric surgery, orthopedic surgery, hand surgery, cosmetic surgery, general surgery and more. Our comprehensive bariatric surgery program sets a new paradigm, providing personalized care and education prior to surgery thus maximizing patient success with our complete bariatric aftercare program. Our bariatric team is comprised of various care professionals focused on the medical, nutritional, fitness and mental health of each patient.
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Soft goods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and Internationally through various distribution sources.
Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures to transform the treatment of glaucoma, one of the world`s leading causes of blindness. Glaukos has pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm. The company launched the iStent Trabecular Micro-Bypass Stent, its first MIGS device, in the United States in 2012. Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of injectable micro-scale therapies designed to address the complete range of glaucoma disease states and progression. Glaukos believes the iStent is the smallest medical device ever approved by the Food and Drug Administration, or FDA, measuring 1.0 mm long and 0.33 mm wide. In June 2015, the company completed an initial public offering and its shares are now traded on the New York Stock Exchange under the ticker symbol "GKOS". Founded in 1998, Glaukos is based in San Clemente, California.